# OnCo record paper-vogelzang-pemetrexed-mesothelioma-jco-2003 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-vogelzang-pemetrexed-mesothelioma-jco-2003/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-vogelzang-pemetrexed-mesothelioma-jco-2003" ;
  schema:name "Phase 3 trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma"@en ;
  schema:description "Adding pemetrexed to cisplatin lengthened survival by almost three months in pleural mesothelioma, making platinum-pemetrexed the first, and for many years the only, standard chemotherapy for the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-vogelzang-pemetrexed-mesothelioma-jco-2003/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2003.11.136>, <https://pubmed.ncbi.nlm.nih.gov/12860938/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2003.11.136> ;
  schema:datePublished "2003"^^xsd:gYear ;
  schema:author "Vogelzang NJ, Rusthoven JJ, Symanowski J, et al." ;
  onco:cancers <https://onco.cc/cancers/pleural-mesothelioma/>, <https://onco.cc/cancers/peritoneal-mesothelioma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/pemetrexed/> ;
  onco:journals <https://onco.cc/journals/jco/> .